By allowing the federal government to negotiate with drug makers, Medicare and its beneficiaries could save an estimated $2.8 billion in a single year for the top 20 most commonly prescribed medicines, according to a new analysis by Democrats on the Senate Homeland Security and Governmental Affairs Committee. In crunching the numbers, the committee staff…
This article is available to Insider Pro subscribers only.Sign in or register to be an Insider Pro and access ALL LOCKED articles.
Candidates for Phelps County Primary Election, Associate Circuit Judge-Division 1 and Probate
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News